1.295
Standard Biotools Inc Borsa (LAB) Ultime notizie
TD Cowen Downgrades Standard BioTools to Hold From Buy, $1.60 Price Target - MarketScreener
Standard BioTools Second Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag - uk.finance.yahoo.com
Can Traders Expect Breakout From Standard BioTools Inc. This Week [Sell Signal]Free Weekly Breakout Stock Alerts - 선데이타임즈
Standard BioTools stock holds Sector Weight rating at KeyBanc amid M&A potential - Investing.com Australia
KeyBanc Maintains Standard BioTools(LAB.US) With Hold Rating - 富途牛牛
Standard BioTools Delays Quarterly Report Filing - TipRanks
Standard BioTools Reports Q2 2025 Financial Results - TipRanks
Standard BioTools Reports Q2 Loss, Tops Revenue Estimates - AInvest
Standard BioTools Expects FY25 Revenue of $165M-$175M - AInvest
Standard BioTools Steadies Revenue Despite Tough Market Headwinds - Finimize
Standard BioTools (LAB) Reports Q2 Loss, Tops Revenue Estimates - Nasdaq
Standard BioTools: Q2 Earnings Snapshot - San Francisco Chronicle
Standard BioTools Q2 rev. $42mln, SomaLogic sold to Illumina for up to $425mln. - AInvest
Standard BioTools Announces SomaLogic Sale to Illumina - TipRanks
Standard Biotools earnings beat by $0.02, revenue fell short of estimates - Investing.com Canada
Standard BioTools Q2 revenue dips 3% - MarketScreener
Standard BioTools Reports Second Quarter 2025 Financial Results - The Manila Times
Standard BioTools' Five-Year Share Price Down 84%, Revenue Growth of 3.1% - AInvest
The past five years for Standard BioTools (NASDAQ:LAB) investors has not been profitable - Yahoo Finance
Standard BioTools LAB Q2 2025 Earnings Preview Upside Potential on Strategic Expansion - AInvest
Standard BioTools Inc expected to post a loss of 8 cents a shareEarnings Preview - TradingView
Standard BioTools Q2 2025 Earnings Preview - MSN
Standard BioTools Q2 2025 Earnings Outlook: Strategic Shifts, Revenue Pressures, and the Path to Value Creation - AInvest
What to Expect from Standard BioTools Inc (LAB) Q2 2025 Earnings - Yahoo Finance
Standard BioTools Partners with Precision Health in Singapore for Proteomic Collaboration - AInvest
Standard BioTools and Precision Health Research, Singapore - GlobeNewswire
Major Win: Standard BioTools Secures 100,000-Sample Singapore Biobank Deal for Population Health Study - Stock Titan
Why is Standard BioTools Inc. stock attracting strong analyst attentionUnlock daily stock market insights for success - Jammu Links News
How volatile is Standard BioTools Inc. stock compared to the marketInvest smarter with daily market updates - Jammu Links News
Is Standard BioTools Inc. a growth stock or a value stockBuild wealth with steady, reliable stocks - Jammu Links News
What analysts say about Standard BioTools Inc. stockInvest confidently with data-backed picks - Jammu Links News
How many analysts rate Standard BioTools Inc. as a “Buy”Maximize returns with effective portfolio management - Jammu Links News
What institutional investors are buying Standard BioTools Inc. stockDiscover stocks with explosive potential - Jammu Links News
What makes Standard BioTools Inc. stock price move sharplyMaximize your portfolio’s growth potential - Jammu Links News
Is Standard BioTools Inc. stock overvalued or undervaluedFree Popular Stock Recommendations - Jammu Links News
Is it the right time to buy Standard BioTools Inc. stockInvest smarter with expert stock recommendations - Jammu Links News
What catalysts could drive Standard BioTools Inc. stock higher in 2025Exceptional stock performance - Jammu Links News
What are Standard BioTools Inc. company’s key revenue driversUnlock hidden market opportunities today - Jammu Links News
What are the technical indicators suggesting about Standard BioTools Inc.Build wealth faster with consistent growth stocks - Jammu Links News
When is Standard BioTools Inc. stock expected to show significant growthUnlock expert insights for smarter investing - Jammu Links News
Standard BioTools Approves Stock Awards for Executives - The Globe and Mail
Standard BioTools Inc. Building a Base Near SupportConservative Entry for High Return Setup Backed - beatles.ru
Standard BioTools grants RSU awards to CEO and CFO, increases CFO bonus target - Investing.com Australia
Illumina Beats Q2 Earnings Expectations, Boosts 2025 Outlook Despite Revenue Dip - Stock Titan
Trend analysis for Standard BioTools Inc. this weekFast Return Equity Trade Forecast Points to Small Caps - metal.it
Standard BioTools Inc. At Critical Juncture — Bounce or BreakdownTrade Scanner With Buy Zone Alerts Flagged - metal.it
Best data tools to analyze Standard BioTools Inc. stockAI Driven Stock Trend Forecast Shows Momentum Shift - metal.it
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):